Skip to main content
. 2023 Sep 27;10:1236617. doi: 10.3389/fmolb.2023.1236617

FIGURE 5.

FIGURE 5

The escape of Omicron BQ.1.1 and XBB.1.5 from Bebtelovimab. (A) Mutations in the RBD region of Spike protein of SARS-CoV-2 Omicron variants and their effect on the interface contacts with respect to Bebtelovimab. (B) Mutations in both BQ.1.1 and XBB.1.5 abolish the Bebtelovimab interface. (C) Changes in the binding free energy (BFE, calculated through MMGBSA). Bebtelovimab loses its binding affinity against both new variants.